FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/14/2024
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Quick snapshot
INDUCE-SEQ
ST13
US500000079362452Class
Filing
Registration
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Case type
Recorded events
Latest update
Classification
Trademark type
Nice classes
Filing date
Registration date
Expiration date
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Structured fields from the responsible authority and the official record.
Status date
Last transaction
Responsible office
Status code
Official register
Drawing code
Owner type
Owner location
Examiner
Current location
Holders
Representatives
Brendan J. Hughes Cooley LLP
Nice Classes
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biological preparations for use in agriculture, except fungicides, herbicides, insecticides, and parasiticides
Class 5
Pharmaceutical preparations for the treatment of cancer, cardiovascular diseases and disorders, neurological diseases and disorders, sleep conditions, diseases and disorders, central nervous system conditions, diseases and disorders, rare diseases and disorders, genetic diseases and disorders, oncological and hematological diseases and disorders, dermatological diseases and disorders, bone diseases and disorders, respiratory diseases and disorders, endocrinological diseases and disorders, circulatory diseases and disorders, gastroenterological diseases and disorders, hormonal diseases and disorders, diabetic diseases and disorders, digestive diseases and disorders, muscular diseases and disorders, immune system diseases and disorders, metabolic diseases and disorders, and ocular diseases and disorders; medical diagnostic reagents and assays for testing of body fluids; chemical reagents for medical purposes; pharmaceutical preparations for use in gene and cell therapies for the treatment of cancer, cardiovascular diseases and disorders, psychiatric diseases and disorders, neurological diseases and disorders, sleep conditions, diseases and disorders, central nervous system conditions, diseases and disorders, rare diseases and disorders, genetic diseases and disorders, oncological and hematological diseases and disorders, dermatological diseases and disorders, bone diseases and disorders, respiratory diseases and disorders, endocrinological diseases and disorders, circulatory diseases and disorders, gastroenterological diseases and disorders, hormonal diseases and disorders, diabetic diseases and disorders, digestive diseases and disorders, muscular diseases and disorders, immune system diseases and disorders, metabolic diseases and disorders, and ocular diseases and disorders; pharmaceutical preparations for use in chemotherapies; diagnostic kits for medical purposes comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer, cardiovascular diseases and disorders, psychiatric diseases and disorders, neurological diseases and disorders, sleep conditions, diseases and disorders, central nervous system conditions, diseases and disorders, rare diseases and disorders, genetic diseases and disorders, oncological and hematological diseases and disorders, dermatological diseases and disorders, bone diseases and disorders, respiratory diseases and disorders, endocrinological diseases and disorders, circulatory diseases and disorders, gastroenterological diseases and disorders, hormonal diseases and disorders, diabetic diseases and disorders, digestive diseases and disorders, muscular diseases and disorders, immune system diseases and disorders, metabolic diseases and disorders, and ocular diseases and disorders; analytical test kits being medical diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer, cardiovascular diseases and disorders, psychiatric diseases and disorders, neurological diseases and disorders, sleep conditions, diseases and disorders, central nervous system conditions, diseases and disorders, rare diseases and disorders, genetic diseases and disorders, oncological and hematological diseases and disorders, dermatological diseases and disorders, bone diseases and disorders, respiratory diseases and disorders, endocrinological diseases and disorders, circulatory diseases and disorders, gastroenterological diseases and disorders, hormonal diseases and disorders, diabetic diseases and disorders, digestive diseases and disorders, muscular diseases and disorders, immune system diseases and disorders, metabolic diseases and disorders, and ocular diseases and disorders
Class 9
Downloadable computer software for the analysis of genomic data, gene editing data, cell culture data, therapeutic development data, and patient data; downloadable mobile application software for the analysis of genomic data, gene editing data, cell culture data, therapeutic development data, and patient data; apparatus and instruments for scientific or research purposes, namely, laboratory apparatus and instruments for genome sequencing, not for medical purposes
Class 10
Blood test collection kits comprised of blood collection needles, blood collecting tubes, and blood collection bags for medical purposes; radiation therapy devices
Class 42
Analytical laboratory services, namely, scientific laboratory services; pharmaceutical research and development services; testing, inspection, research and development of pharmaceutical preparations for gene therapy; testing, inspection, research, and development of pharmaceutical preparations for cell therapies; genome scientific research services; development of new technology for others in the field of medical devices and medical diagnostic apparatuses; medical research services; medical research in the field of infectious disease monitoring and surveillance services; research and development services in the field of antibodies; research, development and consultation related thereto in the field of medical devices and medical diagnostic apparatuses through the use of artificial intelligence; medical research in the field of oncology; toxicity testing and analysis for foodstuffs for scientific research purposes; toxicity testing and analysis for household products for scientific research purposes; computer software development; providing temporary use of online non-downloadable software and software applications using artificial intelligence for medical analysis; software as a service (SaaS) featuring software for the analysis of genomic data, gene editing data, cell culture data, therapeutic development data, and patient data; platform as a service (PaaS) featuring computer software platforms for the analysis of genomic data, gene editing data, cell culture data, therapeutic development data, and patient data; providing temporary use of on-line non-downloadable software and software applications using artificial intelligence for medical analysis; providing temporary use of on-line non-downloadable software and software applications for creating analytic and statistic models for data analysis
Class 44
Medical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; medical diagnostic blood testing for identifying and determining the presence and stage of diseases; genome editing therapeutics
History of USPTO decisions and trademark events.
37 publications found
FINAL DECISION TRANSACTION PROCESSED BY IB
12/14/2024
FINAL DISPOSITION NOTICE SENT TO IB
11/21/2024
FINAL DISPOSITION PROCESSED
11/21/2024
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/11/2024
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/11/2024
REGISTERED-PRINCIPAL REGISTER
06/11/2024
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/26/2024
PUBLISHED FOR OPPOSITION
03/26/2024
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/06/2024
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/06/2024
APPROVED FOR PUB - PRINCIPAL REGISTER
02/21/2024
EXAMINER'S AMENDMENT ENTERED
02/21/2024
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/21/2024
EXAMINERS AMENDMENT E-MAILED
02/21/2024
EXAMINERS AMENDMENT -WRITTEN
02/21/2024
TEAS/EMAIL CORRESPONDENCE ENTERED
01/05/2024
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/05/2024
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/05/2024
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
10/12/2023
REFUSAL PROCESSED BY IB
08/01/2023
ATTORNEY REVIEW COMPLETED
07/25/2023
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
07/19/2023
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/08/2023
REFUSAL PROCESSED BY MPU
07/08/2023
CORRECTION TRANSACTION RECEIVED FROM IB
06/11/2023
LIMITATION OF GOODS RECEIVED FROM IB
06/10/2023
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/31/2023
NON-FINAL ACTION WRITTEN
05/30/2023
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
05/26/2023
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/26/2023
NON-FINAL ACTION WRITTEN
05/25/2023
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
05/24/2023
ASSIGNED TO EXAMINER
05/23/2023
LIMITATION OF GOODS RECEIVED FROM IB
04/03/2023
APPLICATION FILING RECEIPT MAILED
02/15/2023
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/11/2023
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/09/2023
Continuous trademark protection
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.